XML 15 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (71,704) $ (10,521)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 1,133 873
Non-cash gain on forgiveness of debt (2,098) 0
Share-based compensation 4,259 1,070
Write-down of inventory to net realizable value 1,581 417
Interest expense from contingent beneficial conversion feature 26,061 0
Common stock warrant liability adjustment (15,745) 0
Preferred stock warrant liability adjustment 5,578 1,952
Other adjustments, net 725 391
Changes in assets and liabilities:    
Accounts receivable (144) (2,962)
Prepaid expenses and other assets (10,493) (989)
Inventory (11,649) (3,468)
Accounts payable and accrued and other expenses 32,117 11,818
Deferred revenues (567) 957
Other, net 390 333
Net cash used in operating activities (40,556) (129)
Cash flows from investing activities    
Purchase of property and equipment (969) (967)
Purchase of intangible assets (1,051) (89)
Net cash used in investing activities (2,020) (1,056)
Cash flows from financing activities    
Proceeds from short-term borrowings 13,708 12,953
Payments of short-term borrowings (21,194) (11,687)
Proceeds from long-term borrowings 5,000 3,000
Payments of long-term borrowings (1,000) 0
Proceeds from Paycheck Protection Program loan 0 2,075
Proceeds from reverse recapitalization and PIPE financing, net of $11,610 and $0, respectively, of transaction costs 133,889 0
Payments for cash payout of stock options as result of the Merger (Note 3) (9,890) 0
Other, net 108 117
Net cash provided by financing activities 120,621 6,458
Net change in cash and cash equivalents 78,045 5,273
Cash and cash equivalents at beginning of period 17,009 11,736
Cash and cash equivalents at end of period 95,054 17,009
Supplemental disclosure of non-cash financing activities:    
Conversion of redeemable convertible preferred stock to common stock 47,188 0
Conversion of related party convertible notes to common stock 33,183 0
Common stock warrants received as part of the Merger $ 22,806 $ 0